CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

NCT06783309 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus
T1D
T1DM
T1DM - Type 1 Diabetes Mellitus
Type 1 Diabetes in Adolescence
Type 1 Diabetes in Children
Type 1 Diabetes (Juvenile Onset)
Type 1 Diabetes
Type 1 Diabetes Patients
Type 1 Diabetes Mellitis

Interventions

DRUG: CNP-103
DRUG: Placebo

Sponsor

COUR Pharmaceutical Development Company, Inc.